Orthofix Medical Inc.
OFIXNasdaqCIK 884624HealthcareFiscal year ends Dec 23
Reports and events: 368 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-01-0816:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002924 |
| 2023-12-1516:14 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-070740 |
| 2023-12-1317:16 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-23-002760 |
| 2023-12-0116:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-067364 |
| 2023-11-0816:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061148 |
| 2023-11-0816:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-061122 |
| 2023-11-0816:09 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-061099 |
| 2023-11-0317:15 ET | SC 13D | Ownership report, active investor | 0000921895-23-002456 |
| 2023-10-0519:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-052018 |
| 2023-10-0317:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-051671 |
| 2023-09-1421:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-234766 |
| 2023-08-0816:28 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039884 |
| 2023-08-0816:24 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-039871 |
| 2023-06-2107:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-029063 |
| 2023-06-2016:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-028907 |
| 2023-06-1516:58 ET | 8-K | 9.01 Financial statements and exhibits | 0000950170-23-028350 |
| 2023-05-0916:21 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019721 |
| 2023-05-0916:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-019696 |
| 2023-04-2717:06 ET | DEF 14A | Proxy statement | 0000950170-23-015379 |
| 2023-04-0717:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-012209 |
| 2023-03-1307:29 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-23-007437 |
| 2023-03-0616:11 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-006242 |
| 2023-03-0616:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-006239 |
| 2023-02-1319:03 ET | 8-K/A | 9.01 Financial statements and exhibits | 0000950170-23-002508 |
| 2023-01-0907:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-000431 |
| 2023-01-0506:08 ET | 8-K | 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-001900 |
| 2023-01-0416:31 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-001527 |
| 2022-12-2717:26 ET | 8-K | 8.01 Other events | 0001193125-22-312734 |
| 2022-12-0517:24 ET | 8-K | 8.01 Other events | 0001193125-22-298551 |
| 2022-11-3017:25 ET | 8-K | 8.01 Other events | 0001193125-22-295519 |
| 2022-11-2121:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-289289 |
| 2022-11-0307:13 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-021538 |
| 2022-11-0307:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-021534 |
| 2022-10-1106:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-260160 |
| 2022-10-1106:29 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-260149 |
| 2022-08-0507:34 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-014951 |
| 2022-08-0507:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-014943 |
| 2022-06-0707:36 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-22-011247 |
| 2022-05-0607:58 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-007997 |
| 2022-05-0607:57 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-007996 |
| 2022-04-2716:30 ET | DEF 14A | Proxy statementPeriod 2022-06-06 | 0001564590-22-016085 |
| 2022-04-0807:19 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-22-005488 |
| 2022-02-2508:21 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-006929 |
| 2022-02-2508:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-006928 |
| 2022-01-1007:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-000766 |
| 2021-12-1407:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-060217 |
| 2021-11-0508:21 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-054754 |
| 2021-11-0508:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-054753 |
| 2021-09-2907:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-049312 |
| 2021-09-2308:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-048661 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 17:00 ET. Listed shows no prices and gives no investment advice.